Salveen Richter
Stock Analyst at Goldman Sachs
(4.66)
# 835
Out of 4,685 analysts
538
Total ratings
51.3%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Maintained: Hold | $27 → $28 | $26.26 | +6.63% | 14 | Aug 20, 2026 | |
| MRNA Moderna | Rated: Hold | $67 → $120 | $142.77 | -15.95% | 48 | Aug 19, 2026 | |
| TSHA Taysha Gene Therapies | Maintained: Buy | $13 | $5.96 | +118.12% | 7 | Aug 11, 2026 | |
| CRSP CRISPR Therapeutics AG | Rated: Hold | $48 → $55 | $59.37 | -7.36% | 17 | Aug 10, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintained: Buy | $21 | $18.01 | +16.60% | 1 | Aug 10, 2026 | |
| VTRS Viatris | Maintained: Hold | $16 → $20 | $16.89 | +18.41% | 3 | Aug 6, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Sell | $9 | $13.11 | -31.35% | 18 | Aug 6, 2026 | |
| ANNX Annexon | Maintained: Hold | $7 | $5.25 | +33.33% | 2 | Aug 6, 2026 | |
| AMGN Amgen | Maintained: Buy | $389 → $450 | $436.99 | +2.98% | 21 | Aug 5, 2026 | |
| ELVN Enliven Therapeutics | Rated: Buy | $67 → $80 | $60.50 | +32.23% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $62 | $50.83 | +21.98% | 4 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $652 → $653 | $547.55 | +19.26% | 29 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 | $148.86 | -12.67% | 16 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $965 → $972 | $807.71 | +20.34% | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 → $118 | $127.74 | -7.62% | 27 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $66 → $69 | $62.43 | +10.52% | 17 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $49.56 | -7.18% | 23 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $14.33 | +186.11% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $34.28 | -6.65% | 17 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $31 | $19.42 | +59.63% | 12 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $14.91 | +121.33% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $221.50 | +12.87% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $550 | $236.56 | +132.50% | 22 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 | $134.96 | -34.05% | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $23.56 | +74.02% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $28.87 | +21.23% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $127 → $69 | $65.29 | +5.68% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $26 | $15.77 | +64.87% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $17 | $21.59 | -21.26% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $30.59 | -47.70% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $15 → $17 | $29.73 | n/a | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $10.88 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $40 | $24.67 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.25 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $3.62 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $30 | $20.16 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $5 | $26.44 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $78.68 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $66.95 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $61.92 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $3.30 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $31 | $2.09 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $270.58 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $3.64 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $14.61 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $8.40 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $9 | $3.44 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $6 | $4.09 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $4.33 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $126 → $131 | $543.69 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 | $3.56 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $4.52 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $47 | $88.59 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $2 | $10.13 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $527.91 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $2.80 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0001 | n/a | 1 | Dec 2, 2011 |
Ultragenyx Pharmaceutical
Aug 20, 2026
Maintained: Hold
Price Target: $27 → $28
Current: $26.26
Upside: +6.63%
Moderna
Aug 19, 2026
Rated: Hold
Price Target: $67 → $120
Current: $142.77
Upside: -15.95%
Taysha Gene Therapies
Aug 11, 2026
Maintained: Buy
Price Target: $13
Current: $5.96
Upside: +118.12%
CRISPR Therapeutics AG
Aug 10, 2026
Rated: Hold
Price Target: $48 → $55
Current: $59.37
Upside: -7.36%
Amneal Pharmaceuticals
Aug 10, 2026
Maintained: Buy
Price Target: $21
Current: $18.01
Upside: +16.60%
Viatris
Aug 6, 2026
Maintained: Hold
Price Target: $16 → $20
Current: $16.89
Upside: +18.41%
Intellia Therapeutics
Aug 6, 2026
Maintained: Sell
Price Target: $9
Current: $13.11
Upside: -31.35%
Annexon
Aug 6, 2026
Maintained: Hold
Price Target: $7
Current: $5.25
Upside: +33.33%
Amgen
Aug 5, 2026
Maintained: Buy
Price Target: $389 → $450
Current: $436.99
Upside: +2.98%
Enliven Therapeutics
Aug 5, 2026
Rated: Buy
Price Target: $67 → $80
Current: $60.50
Upside: +32.23%
Aug 5, 2026
Maintained: Buy
Price Target: $58 → $62
Current: $50.83
Upside: +21.98%
Aug 4, 2026
Rated: Buy
Price Target: $652 → $653
Current: $547.55
Upside: +19.26%
Aug 3, 2026
Maintained: Hold
Price Target: $130
Current: $148.86
Upside: -12.67%
Jul 30, 2026
Maintained: Buy
Price Target: $965 → $972
Current: $807.71
Upside: +20.34%
Jul 29, 2026
Maintained: Hold
Price Target: $110 → $118
Current: $127.74
Upside: -7.62%
Jul 29, 2026
Maintained: Hold
Price Target: $66 → $69
Current: $62.43
Upside: +10.52%
Jul 29, 2026
Maintained: Hold
Price Target: $46
Current: $49.56
Upside: -7.18%
Jul 28, 2026
Maintained: Buy
Price Target: $41
Current: $14.33
Upside: +186.11%
Jul 21, 2026
Maintained: Hold
Price Target: $32
Current: $34.28
Upside: -6.65%
Jul 20, 2026
Maintained: Buy
Price Target: $22 → $31
Current: $19.42
Upside: +59.63%
Jul 20, 2026
Maintained: Buy
Price Target: $33
Current: $14.91
Upside: +121.33%
Jul 13, 2026
Maintained: Buy
Price Target: $250
Current: $221.50
Upside: +12.87%
Jun 25, 2026
Maintained: Buy
Price Target: $550
Current: $236.56
Upside: +132.50%
Jun 10, 2026
Maintained: Hold
Price Target: $89
Current: $134.96
Upside: -34.05%
Jun 1, 2026
Maintained: Buy
Price Target: $41
Current: $23.56
Upside: +74.02%
May 13, 2026
Maintained: Buy
Price Target: $35
Current: $28.87
Upside: +21.23%
May 11, 2026
Initiated Coverage: Hold
Price Target: $127 → $69
Current: $65.29
Upside: +5.68%
Apr 9, 2026
Maintained: Buy
Price Target: $14 → $26
Current: $15.77
Upside: +64.87%
Feb 25, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $21.59
Upside: -21.26%
Oct 30, 2025
Maintained: Hold
Price Target: $16
Current: $30.59
Upside: -47.70%
Aug 7, 2025
Maintained: Sell
Price Target: $15 → $17
Current: $29.73
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $19
Current: $10.88
Upside: n/a
Jan 28, 2025
Maintained: Buy
Price Target: $46 → $40
Current: $24.67
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $9.25
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $3.62
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $37 → $30
Current: $20.16
Upside: n/a
Feb 16, 2024
Maintained: Hold
Price Target: $48 → $5
Current: $26.44
Upside: n/a
Jan 8, 2024
Maintained: Buy
Price Target: n/a
Current: $78.68
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $66.95
Upside: n/a
Jul 31, 2023
Maintained: Buy
Price Target: $53
Current: $61.92
Upside: n/a
Jun 12, 2023
Maintained: Sell
Price Target: $7
Current: $3.30
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $32 → $31
Current: $2.09
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $225
Current: $270.58
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $3.64
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $14.61
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $2 → $1
Current: $8.40
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $8 → $9
Current: $3.44
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $34 → $6
Current: $4.09
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $4.33
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $126 → $131
Current: $543.69
Upside: n/a
Nov 9, 2020
Maintained: Sell
Price Target: $11
Current: $3.56
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $4.52
Upside: n/a
May 8, 2020
Maintained: Hold
Price Target: $45 → $47
Current: $88.59
Upside: n/a
Nov 13, 2019
Maintained: Sell
Price Target: $4 → $2
Current: $10.13
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $527.91
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $2.80
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.0001
Upside: n/a